Tiger Pharmaceuticals (03347.HK) shareholder Cao Xiaochun plans to reduce his holdings of the company's shares by no more than 3 million shares.

date
29/07/2025
Financial news from the Wise News app, Taige Pharmaceuticals (03347.HK) announced that the company recently received a notification letter from Ms. Cao Xiaochun, a shareholder, director, and general manager holding more than 5% of the company's shares, regarding her plan to reduce the company's shares: Ms. Cao Xiaochun holds 51.6618 million shares of the company (accounting for 6.0413% of the total share capital of the company after excluding the shares in the buyback account, and 7.0575% of the total A shares of the company), planning to reduce the company's shares by no more than 3 million shares (accounting for 0.3508% of the total share capital of the company after excluding the shares in the buyback account, and 0.4098% of the total A shares of the company) through centralized bidding and/or block trading within 3 months after the date of this announcement (without reducing during the window period) for 15 trading days.